Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism.
Schroeder
V
V
Laboratory for Thrombosis Research, Department of Clinical Research, Inselspital, University Hospital of Bern, Switzerland.
Kucher
N
N
Kohler
H P
HP
D000208:Acute Disease; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation; D025901:Carboxypeptidase B2 / Q000097:blood / Q000502:physiology*; D016022:Case-Control Studies; D005342:Fibrinolysis; D006801:Humans; D011655:Pulmonary Embolism / Q000097:blood* / Q000175:diagnosis; D012720:Severity of Illness Index
D015415:Biomarkers; D025901:Carboxypeptidase B2